Tech stocks led a selloff in the first minutes of trading on Monday as doubts about high-running valuations preyed on ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

Sarepta Therapeutics' shares plunged nearly 40% in premarket trading on Tuesday as failure of two of its approved drugs for a ...

The United States on Tuesday imposed sanctions on a group of bankers, financial institutions and others accused of laundering ...

Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...

() -Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a muscle-wasting ...

Palantir (PLTR) stock fell Tuesday as Wall Street analysts debated whether its latest solid earnings report justified its ...

China’s Commerce Ministry said Tuesday that the Netherlands’ seizure of Chinese-owned chipmaker Nexperia has caused “chaos” ...

Ferrari has trimmed price increases on some of the models it sells in the U. to a maximum of 5% following a deal to reduce ...

Novo Nordisk is now offering up to $10 billion for Metsera, up from its prior offer of up to $8.5 billion, the obesity drug ...

Midland cut its 2025 profit forecast for a third straight quarter on Tuesday as U. biofuel policy uncertainty and global ...